Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.vimta.com | |
Market Cap | 963.09 Cr. | |
Enterprise Value(EV) | 956.24 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 18.70 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 23.23 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 63.07 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 133.88 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.25 | Calculated using Price: 434.50 |
Dividend Yield | 0.46 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.22 Cr. | 22,165,365 Shares |
FaceValue | 2 | |
About Vimta Labs Ltd. | ||
Vimta Labs is India's leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe. |
1 Day |
|
-1.14% |
1 Week |
|
+4.08% |
1 Month |
|
+2.75% |
3 Month |
|
-25.17% |
6 Month |
|
+3.16% |
1 Year |
|
+1.95% |
2 Year |
|
+5.05% |
5 Year |
|
+68.33% |
10 Year |
|
+709.90% |
4 years | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 3.96 | 11.66 | 19.43 | 19.02 | |
Return on Capital Employed (%) | 5.84 | 14.25 | 23.92 | 24.59 | |
Return on Assets (%) | 2.79 | 8.25 | 14.29 | 14.53 |
Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 173 | 194 | 234 | 282 | 297 | |
Non Curr. Liab. | 15 | 25 | 23 | 19 | 16 | |
Curr. Liab. | 58 | 54 | 48 | 57 | 58 | |
Minority Int. | ||||||
Equity & Liab. | 245 | 273 | 305 | 358 | 371 | |
Non Curr. Assets | 149 | 163 | 181 | 194 | 216 | |
Curr. Assets | 96 | 111 | 124 | 164 | 155 | |
Misc. Exp. not W/O | ||||||
Total Assets | 245 | 273 | 305 | 358 | 371 |
Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 181 | 211 | 278 | 318 | 316 | |
Other Income | 3 | 1 | 1 | 3 | 4 | |
Total Income | 184 | 212 | 280 | 322 | 321 | |
Total Expenditure | -151 | -158 | -198 | -223 | -230 | |
PBIDT | 33 | 54 | 82 | 98 | 91 | |
Interest | -4 | -2 | -2 | -3 | -2 | |
Depreciation | -21 | -23 | -23 | -31 | -33 | |
Taxation | -1 | -7 | -14 | -17 | -14 | |
Exceptional Items | -1 | |||||
PAT | 7 | 21 | 41 | 48 | 41 | |
Minority Interest | ||||||
Share Associate | ||||||
Other Related Items | ||||||
Consolidated Net Profit | 7 | 21 | 41 | 48 | 41 | |
Adjusted EPS | 3 | 10 | 19 | 22 | 19 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 24 | 37 | 59 | 88 | |
Cash Fr. Inv. | -21 | -32 | -38 | -57 | |
Cash Fr. Finan. | -1 | -5 | -17 | -11 | |
Net Change | 3 | 1 | 5 | 20 | |
Cash & Cash Eqvt | 6 | 6 | 11 | 31 |
Thu, 07 Dec 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Wed, 06 Dec 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Fri, 17 Nov 2023
Alteration Of Capital and Fund Raising-XBRL
|
Fri, 08 Dec 2023 |
|
|
|
|
|